Guduchi Sawras (Tinospora cordifolia): An Ayurvedic drug treatment modulates the impaired lipid metabolism in alcoholics through dopaminergic neurotransmission and anti-oxidant defense system

Biomedicine and Pharmacotherapy

Volumn 83, Issue , 2016, Pages 1265-1277

  Shirolkar, Amey ^b   Sharma, Bhawana ^a   Lata, Suman ^a   Dabur, Rajesh ^a,b  

^a MAHARSHI DAYANAND UNIVERSITY   (India)

^b National Research Institute of Basic Ayurvedic Sciences   (India)

Author keywords

Alcoholism; HPLC Q TOF MS; Lipid metabolism; Oxidative stress; Peroxisome proliferator activated receptors; Tinospora cordifolia

Indexed keywords

13 METHYLBERBERINE; 2 METHYLBENZENETHIOL; 25 HYDROXYERGOCALCIFEROL; 8 HYDROXYCOLUMBIN; 8 HYDROXYTINOSPORIDE; AMRITOSIDE D; ANTILIPEMIC AGENT; ANTIOXIDANT; ARGININE; AYURVEDIC DRUG; C HEXOSYL CHRYSOERIOL; COLUMBIN; CORDIFOLIDE B; CRYPTOTANSHINONE; DRUGS USED IN THE TREATMENT OF ADDICTION; HOMOSERINE; HYDROXYL TANSHINONE IIB; JATRORRHIZINE; N ISOVALEROYLGLYCINE; OCTOSANOL; OXACEPROL; PALMATINE; PRZEWAQUINONE A; S ADENOSYLMETHIONINE; SPHINGANINE; SYRINGIN; TETRAHYDROJATRORRHIZINE; TINOSPORA CORDIFOLIA EXTRACT; TINOSPORACLERODANOID; UNCLASSIFIED DRUG; UNINDEXED DRUG; DOPAMINE; DOPAMINE 1 RECEPTOR; PLANT EXTRACT;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOLISM; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AYURVEDA; BLOOD BIOCHEMISTRY; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC TRANSMISSION; ENZYME ACTIVITY; GLYCOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERLIPIDEMIA; LIPID METABOLISM; MALE; MORNING DOSAGE; OXIDATIVE STRESS; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN INTERACTION; QUADRUPOLE MASS SPECTROMETRY; SEROTONIN METABOLISM; SIGNAL TRANSDUCTION; TIME OF FLIGHT MASS SPECTROMETRY; TINOSPORA CORDIFOLIA; TRIACYLGLYCEROL BLOOD LEVEL; URINE LEVEL; AGONISTS; COHORT ANALYSIS; DOPAMINERGIC NERVE CELL; DRUG EFFECTS; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY; SYNAPTIC TRANSMISSION; TINOSPORA; TREATMENT OUTCOME;

ADULT; ALCOHOLICS; ALCOHOLISM; ANTIOXIDANTS; COHORT STUDIES; DOPAMINE; DOPAMINERGIC NEURONS; HUMANS; LIPID METABOLISM; MALE; MEDICINE, AYURVEDIC; PLANT EXTRACTS; RECEPTORS, DOPAMINE D1; SYNAPTIC TRANSMISSION; TINOSPORA; TREATMENT OUTCOME;

EID: 84983381788     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.08.051     Document Type: Article

References (26)

1. [1] Padma, V.V., Baskaran, R., Divya, S., Priya, L.B., Saranya, S., Modulatory effect of Tinospora cordifolia extract on cadmium induced oxidative stress in Wistar rats. Integr. Med. Res. 5 (2016), 48–55.
2. [2] Gupta, P.K., Chakraborty, P., Kumar, S., Singh, P.K., Rajan, M.G., Sainis, K.B., Kulkarni, S., G.1-4A, a Polysaccharide from Tinospora cordifolia inhibits the survival of Mycobacterium tuberculosis by modulating host immune responses in TLR4 dependent manner. PLoS One, 11, 2016, e0154725.
3. [3] Rajalakshmi, M., Anita, R., β-cell regenerative efficacy of a polysaccharide isolated from methanolic extract of Tinospora cordifolia stem on streptozotocin-induced diabetic Wistar rats. Chem. Biol. Interact. 243 (2016), 45–53.
4. [4] Kumari, S., Mittal, A., Dabur, R., Moderate alcohol consumption in chronic form enhances the synthesis of cholesterol and C-21 steroid hormones, while treatment with Tinospora cordifolia modulates these events in men. Steroids, 2016, 10.1016/j.steroids.2016.03.016 in press.
5. [5] Sangeetha, M.K., Priya, C.M., Vasanthi, H.R., Anti-diabetic property of Tinospora cordifolia and its active compound is mediated through the expression of Glut-4 in L6 myotubes. Phytomedicine 20 (2013), 246–248.
6. [6] Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., Wang, S., Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat. Med. 10 (2004), 1344–1351.
7. [7] Sivasubramanian, A., Gadepalli Narasimha, K.K., Rathnasamy, R., Campos, A.M., A new antifeedant clerodane diterpenoid from Tinospora cordifolia. Nat. Prod. Res. 27 (2013), 1431–1436.
8. [8] Dhingra, D., Goyal, P.K., Evidences for the involvement of monoaminergic and GABAergic systems in antidepressant-like activity of Tinospora cordifolia in mice. Ind. J. Pharm. Sci., 70, 2008, 761.
9. [9] Kosaraju, J., Chinni, S., Roy, P.D., Kannan, E., Antony, A.S., Kumar, M.S., Neuroprotective effect of Tinospora cordifolia ethanol extract on 6-hydroxy dopamine induced Parkinsonism. Ind. J. Pharmacol., 46, 2014, 176.
10. [10] Mittal, A., Dabur, R., Detection of new human metabolic urinary markers in chronic alcoholism and their reversal by aqueous extract of Tinospora cordifolia stem. Alcohol Alcohol. 50 (2015), 271–281.
11. [11] Sharma, B., Dabur, R., Protective effects of Tinospora cordifolia on hepatic and gastrointestinal toxicity induced by chronic and moderate alcoholism. Alcohol Alcohol. 51 (2016), 1–10.
12. [12] Dabur, R., Mittal, A., Detection and qualitative analysis of fatty acid amides in the urine of alcoholics using HPLC-QTOF-MS. Alcohol 52 (2016), 71–78.
13. [13] McIlwrath, S.L., Westlund, K.N., Pharmacological attenuation of chronic alcoholic pancreatitis induced hypersensitivity in rats. WJG 21 (2015), 836–853.
14. [14] Blednov, Y.A., Benavidez, J.M., Black, M., Ferguson, L.B., Schoenhard, G.L., Goate, A.M., Edenberg, H.J., Wetherill, L., Hesselbrock, V., Foroud, T., Adron Harris, R., Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humans. Alcohol Clin. Exp. Res. 39 (2015), 136–145.
15. [15] Chen, H., Yuan, B., Miao, H., Tan, Y., Bai, X., Zhao, Y.Y., Wang, Y., Urine metabolomics reveals new insights into hyperlipidemia and the therapeutic effect of rhubarb. Anal. Methods 7 (2015), 3113–3123.
16. [16] Shirolkar, A., Gahlaut, A., Hooda, V., Dabur, R., Phytochemical composition changes in untreated stem juice of Tinospora cordifolia (W) Mier during refrigerated storage. J. Pharm. Res. 7 (2013), 1–6.
17. [17] Gaulton, A., Bellis, L.J., Bento, A.P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., Overington, J.P., ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res. 40 (2012), D1100–D1107.
18. [18] Kuhn, M., Szklarczyk, D., Pletscher-Frankild, S., Blicher, T.H., von Mering, C., Jensen, L.J., Bork, P., STITCH 4: integration of protein–chemical interactions with user data. Nucleic Acids Res., 28, 2013, p.gkt1207.
19. [19] Patterson, A.D., Slanar, O., Krausz, K.W., Li, F., Hofer, C.C., Perlik, F., Gonzalez, F.J., Idle, J.R., Human urinary metabolomic profile of PPARα induced fatty acid β-oxidation. J. Proteom. Res. 8 (2009), 4293–4300.
20. [20] Matsuda, H., Sato, M., Yakushiji, M., Koshiguchi, M., Hirai, S., Egashira, Y., Regulation of rat hepatic α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase, a key enzyme in the tryptophan-NAD pathway, by dietary cholesterol and sterol regulatory element-binding protein-2. Eur. J. Nutr. 53 (2014), 469–477.
21. [21] Lazennec, G., Canaple, L., Saugy, D., Wahli, W., Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol. Endocrinol. 14 (2000), 1962–1975.
22. [22] Chen, A.C., Shirayama, Y., Shin, K.H., Neve, R.L., Duman, R.S., Expression of the cAMP response element binding protein (CREB) in hippocampus produces an anti-depressant effect. Biol. Psychiatry 49 (2001), 753–762.
23. [23] Chanda, D., Kim, D.K., Li, T., Kim, Y.H., Koo, S.H., Lee, C.H., Chiang, J.Y., Choi, H.S., Cannabinoid receptor type 1 (CB1R) signaling regulates hepatic gluconeogenesis via induction of endoplasmic reticulum-bound transcription factor cAMP-responsive element-binding protein H (CREBH) in primary hepatocytes. J. Biol. Chem. 286 (2011), 27971–27979.
24. [24] Yellaturu, C.R., Deng, X., Cagen, L.M., Wilcox, H.G., Park, E.A., Raghow, R., Elam, M.B., Posttranslational processing of SREBP-1 in rat hepatocytes is regulated by insulin and cAMP. Biochem. Biophys. Res. Commun. 332 (2005), 174–180.
25. [25] Kok, P., Roelfsema, F., Frolich, M., van Pelt, J., Stokkel, M.P., Meinders, A.E., Pijl, H., Activation of dopamine D2 receptors simultaneously ameliorates various metabolic features of obese women. Am. J. Physiol. Endocrinol. Metabol. 291 (2006), E1038–E1043.
26. [26] van Weenen, J.D., Parlevliet, E.T., Maechler, P., Havekes, L.M., Romijn, J.A., Ouwens, D.M., Pijl, H., Guigas, B., The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the α2-adrenergic receptors in beta cells. Biochem. Pharmacol. 79 (2010), 1827–1836.